Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

ClinicalTrials.gov ID: NCT04509674

Public ClinicalTrials.gov record NCT04509674. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 9:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

EMPACT-MI: A Streamlined, Multicentre, Randomised, Parallel Group, Double-blind Placebo-controlled Superiority Trial to Evaluate the Effect of EMPAgliflozin on Hospitalisation for Heart Failure and Mortality in Patients With aCuTe Myocardial Infarction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study in adults who had a heart attack (myocardial infarction). The purpose of this study is to find out whether a medicine called empagliflozin helps to lower the chances of having to go to the hospital for heart failure and whether it lowers the chances of dying from cardiovascular disease. People who are in hospital may join the study soon after being treated for their heart attack. Participants are put into 2 groups by chance. One group takes 1 empagliflozin tablet a day. The other group takes 1 placebo tablet a day. Placebo tablets look like empagliflozin tablets but do not contain any medicine. All participants continue their standard treatment. Empagliflozin belongs to a class of medicines known as SGLT-2 inhibitors. Empagliflozin is a medicine that helps people with type 2 diabetes to lower their blood sugar. Researchers think that empagliflozin might also help people after heart attack who are at risk for heart failure, whether or not they have diabetes. Participants are in the study for about 1 to 2 years. During this time, there are about 4 visits inperson, 2 visits are done either by phone or by use of an mobile application. Results between the empagliflozin and placebo groups are compared. The doctors also regularly check the general health of the participants.

Study identification

NCT ID
NCT04509674
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
6,522 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 16, 2020 (Actual)
Primary completion
Nov 5, 2023 (Actual)
Completion
Nov 5, 2023 (Actual)
Last update posted
Jan 7, 2025

2020 – 2023

United States locations

U.S. sites
85
U.S. states
29
U.S. cities
78
Facility City State ZIP Site status
Advanced Cardiovascular LLC Alexander City Alabama 35010 —
Grandview Medical Center Birmingham Alabama 35243 —
Heart Center Research, LLC Huntsville Alabama 35801 —
Mercy Gilbert Medical Center Gilbert Arizona 85297 —
Arkansas Cardiology, PA Little Rock Arkansas 72205 —
Comprehensive Cardiovascular Medical Group Bakersfield California 93309 —
Valley Clinical Trials, Inc. Covina California 91723 —
Cardiovascular Innovation and Research Center Long Beach California 90813 —
University of California Los Angeles Los Angeles California 90095 —
InvivoCure Mission Hills California 91346 —
Valley Clinical Trials, Inc. Northridge California 91325 —
Valley Clinical Trials, Inc. Pasadena California 91105 —
Kaiser Permanente San Diego California 92123 —
San Diego Cardiac Center San Diego California 92123 —
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance California 90502 —
Interventional Cardiology Medical Group West Hills California 91307 —
George Washington University Medical Faculty Associates Washington D.C. District of Columbia 20037 —
Clearwater Cardiovascular Consultants Clearwater Florida 33756 —
Integrative Research Associates Fort Lauderdale Florida 33312 —
University of Florida Health Jacksonville Jacksonville Florida 32209 —
Cardiology Partners Clinical Research Institute Palm Beach Gardens Florida 33410 —
Charlotte Heart Group Research Center Port Charlotte Florida 33952 —
Grady Memorial Hospital Atlanta Georgia 30303 —
Cardiovascular Consultants of South Georgia, LLC Thomasville Georgia 31792 —
Atlanta Heart Specialists, LLC Tucker Georgia 30084 —
Advanced Heart Care, LLC, Medicoricum, LLC Fairview Heights Illinois 62208 —
Midwest Cardiovascular Research and Education Foundation Elkhart Indiana 46514 —
Cardiovascular Research of Northwest Indiana, LLC Munster Indiana 46321 —
Reid Physician Associates Richmond Indiana 47374 —
Midwest Heart and Vascular Specialists Overland Park Kansas 66211 —
University of Kentucky Medical Center Lexington Kentucky 40536-0200 —
University of Louisville Louisville Kentucky 40202 —
Eastern Maine Medical Center Bangor Maine 04401 —
Cardiovascular Specialists of Central Maryland Columbia Maryland 21044 —
Shady Grove Adventist Hospital Rockville Maryland 20850 —
Healthy Heart Cardiology Grand Rapids Michigan 49546 —
Western Michigan University Kalamazoo Michigan 49009 —
Mid Michigan Medical Center Midland Michigan 48670 —
Michigan Heart, PC Ypsilanti Michigan 48197 —
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407 —
Cardiology Associates Research, LLC Tupelo Mississippi 38801 —
Missouri Cardiovascular Specialists, LLP Columbia Missouri 65201 —
University of Missouri Health System Columbia Missouri 65212 —
North Kansas City Hospital North Kansas City Missouri 64116 —
Gateway Cardiology, PC St Louis Missouri 63128 —
St. Louis Heart and Vascular, P.C. St Louis Missouri 63136 —
Holy Name Medical Center Hackensack New Jersey 07601 —
AtlantiCare Pomona New Jersey 08240 —
The Heart House Vineland New Jersey 08360 —
SJH Cardiology Associates Liverpool New York 13088 —
Stony Brook University Hospital Stony Brook New York 11794 —
Asheville Cardiology Associates Asheville North Carolina 28803 —
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27517 —
Duke University Medical Center Durham North Carolina 27705 —
Moses H. Cone Memorial Hospital Greensboro North Carolina 27401 —
Medication Management, LLC Greensboro North Carolina 27405 —
North Carolina Heart and Vascular Raleigh North Carolina 27607 —
Trinity Health Center Medical Arts Minot North Dakota 58701 —
Aultman Hospital Canton Ohio 44710 —
Cincinnati VA Medical Center Cincinnati Ohio 45220 —
Kettering Medical Center Kettering Ohio 45429 —
Oklahoma Heart Hospital Research Foundation, Incorporated Oklahoma City Oklahoma 73120 —
South Oklahoma Heart Research Group Oklahoma City Oklahoma 73135 —
Capital Area Research, LLC Camp Hill Pennsylvania 17011 —
Penn Presbyterian Medical Center Philadelphia Pennsylvania 19104 —
Guthrie Medical Group PC Sayre Pennsylvania 18840 —
Upstate Cardiology, PA Greenville South Carolina 29607 —
Carolina Heart Specialists, LLC Lancaster South Carolina 29720 —
Monument Health Rapid City South Dakota 57701 —
Centennial Heart Cardiovascular Consultants, LLC Nashville Tennessee 37203 —
Parkway Cardiology Associates Oak Ridge Tennessee 37830 —
Cardiovascular Research of Knoxville Powell Tennessee 37849 —
Texas Health Presbyterian Hospital Allen Allen Texas 75013 —
Amarillo Heart Clinical Research Institute, Incorporated Amarillo Texas 79106 —
Pharmatex Research Amarillo Texas 79109 —
Dallas VA Medical Center Dallas Texas 75216 —
Baylor Scott and White Health Plano Texas 75093 —
South Texas Cardiovascular Consultants San Antonio Texas 78201 —
Revival Research Institute, LLC. Sherman Texas 75092 —
Cardiovascular Associates of East Texas, PA Tyler Texas 75701 —
Carient Heart and Vascular Manassas Virginia 20109 —
Riverside Regional Medical Center Newport News Virginia 23601 —
Tidewater Physicians Multispecialty Group Newport News Virginia 23606 —
Sentara Hospitals Norfolk Virginia 23507 —
Roanoke Heart Institute PLC Roanoke Virginia 24014 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 354 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04509674, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2025 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04509674 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →